Why some drugs must never be given into the spine

Some chemotherapy medicines are safe when given into a vein but cause catastrophic damage if injected by mistake into the fluid around the spinal cord and brain. The best-known example is vincristine, a medicine widely used for leukaemias, lymphomas and some childhood cancers. Related medicines such as vinblastine and vinorelbine carry the same danger. When these medicines enter the spinal fluid, they destroy nerve tissue as they spread upwards, causing progressive paralysis and almost always death. There is no reliable treatment once it has happened. Worldwide, this rare error has occurred many times, often when a patient was due to receive both an intravenous medicine and a separate spinal injection on the same day.

Because the consequences are so severe, hospitals use strict, layered safeguards to prevent it. Vincristine and related medicines are prepared in small drip bags rather than syringes, so they physically cannot be connected to a spinal needle in the usual way. They carry bold warning labels stating that they are for intravenous use only and fatal if given by other routes. Spinal chemotherapy is given in a different place or at a different time from intravenous vinca medicines, using special connectors that do not fit ordinary drip lines where available. Two trained staff check the medicine, route and patient before any spinal injection. Families have a legitimate role in safety: it is reasonable to ask which medicines are being given, by which route, and how these checks are carried out.

Spinal chemotherapy is important and safe with checks

Medicines such as methotrexate and cytarabine are routinely and safely given into the spine for some cancers.

The danger is a mix-up of route

The risk comes from confusing medicines or syringes when both types are due on the same day.

Asking questions is welcome

Staff should be comfortable explaining which medicine is being given and how it is checked.

It cannot tell you how a particular hospital organises its safeguards. Systems differ, and your team can explain their own procedures. It is also not meant to make you afraid of necessary treatment; these errors are extremely rare where safeguards are followed.

It cannot advise on your own treatment plan. If you have questions about which medicines you receive and how, ask your oncologist or nurse.

Why this information is shared

Patient safety organisations encourage families to understand key safeguards and feel able to ask questions.

Spinal chemotherapy remains essential

For some cancers, treatment into the spinal fluid prevents or treats disease in the brain and spinal cord.

Children and parents

Parents of children with leukaemia often see both types of treatment. Ask the team to explain the schedule.

Speaking up is appropriate

Good teams welcome questions and will pause to double check if asked.

Medication names

Knowing the names of your medicines and routes helps you follow what is happening.

Treatment schedules

Ask for a written schedule showing which medicines are drips and which are spinal.

Other wrong-route risks

Hospitals also guard against other route errors with labelling and checks.

Reporting concerns

If you have a safety concern, you can raise it with the ward in-charge or hospital quality team.

Why errors have happened in the past

Investigations into wrong-route errors around the world have found similar patterns. Often, a patient was due to receive an intravenous vinca medicine and a spinal injection on the same day. Both medicines arrived together, sometimes in similar-looking syringes. Staff were busy, junior, unfamiliar with the procedure or working out of hours. The spinal procedure was done in a place where intravenous medicines were also present, and checks were rushed or skipped. Each of these factors has led to specific safeguards: separate delivery of spinal and intravenous medicines, restricting who can give spinal chemotherapy, doing spinal procedures only in designated areas and times, and making vinca medicines physically difficult to connect to spinal needles.

A shared responsibility for safety

Patient safety experts describe these safeguards as layers, where each layer catches errors that slip through another. Patients and families can act as one more layer by knowing the plan, noticing if something looks different, and speaking up. Staff who are well trained will not be offended; they will simply stop, check and explain. This is especially important for parents of children with leukaemia, who may attend many procedures over a long course of treatment and often become very familiar with the usual routine.

If you have concerns about a past procedure

If you ever feel a safety check was not done properly, raise it with the treating team or the hospital quality department so it can be reviewed and systems improved.

What to do next

If you or your child have spinal chemotherapy, ask for a written schedule of medicines and routes, ask how intravenous and spinal medicines are kept separate and checked, speak up if anything seems unclear, and report any new weakness, numbness or severe pain after treatment immediately.